Abstract

Guideline Question 1. Is there a role for high dose rate endobronchial brachytherapy (HDREB) in the palliation of respiratory symptoms in patients with non-small cell lung cancer? 2. If so, what is the optimal dose of HDREB in this setting? Target Population The recommendations apply to adult patients with symptomatic endobronchial disease in non-small cell lung cancer.